Clinical trial
Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057)
NCT00403793 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00403793 |
|---|---|
| Title | Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057) |
| Official title | A Phase II -b, Placebo-Controlled Trial Investigating the Efficacy, Safety and Pharmacokinetics of a Subcutaneous Etonogestrel Implant Combined With i.m. Testosterone Undecanoate for Male Contraception |
| Lead sponsor | Organon and Co, Industry |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | etonogestrel with testosterone undecanoate, Placebo |
| Enrollment | 350 |
| Start date | Oct 1, 2003 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Nov 27, 2006 |
| Last update posted | Feb 4, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: